0.00 3.12
Prev Close 0.03
Open 0.03
Day Low/High 0.03 / 0.04
52 Wk Low/High 0.03 / 0.77
Volume 2.31M
Exchange OTC
Shares Outstanding 38.32B
Market Cap 1.42M
Div & Yield N.A. (N.A)

Propanc Biopharma Completes Successful Reproduction Run For PRP

Company Requests Scientific Advice Meeting with the MHRA (UK) to Discuss Next Steps

Propanc Biopharma Receives Allowance Of Key Patent Application In The EU

Patent covers a pharmaceutical composition for treating cancer comprising trypsinogen and chymotrypsinogen within the European Union

Propanc Biopharma Is Readied for Revolutionary Cancer Treatment, CEO Says

With a promising treatment for solid tumor cancers coming down its pipeline, Propanc has its sights set on changing the way cancer is treated.